Jeremy Bender, Chief Executive Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 23,141 shares at $23.15 ($537K) on 2022-09-01, disclosed to the SEC on 2022-09-06.
Open-market sale of $537k DAWN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.15 | 10,641 | $246K | 45.9% |
| 2 | $23.15 | 10,641 | $246K | 45.9% |
| 3 | $23.79 | 1,859 | $44K | 8.2% |
| Total | $23.20 avg | 23,141 | $537K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |